Effectiveness of 23-valent pneumococcal polysaccharide vaccine on elderly long-term cancer survivors: a population-based propensity score matched cohort study

OBJECTIVE: The Advisory Committee on Immunization Practices in 2012 recommended the 23-valent pneumococcal polysaccharide vaccine (PPSV23) for adults with high risk of pneumonia. However, its effectiveness in cancer survivors has not been investigated. Our aim was to investigate the effectiveness of...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiou, Wen-Yen, Lee, Moon-Sing, Hung, Shih-Kai, Lin, Hon-Yi, Lo, Yuan-Chen, Hsu, Feng-Chun, Tsai, Shiang-Jiun, Li, Chung-Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5961613/
https://www.ncbi.nlm.nih.gov/pubmed/29769253
http://dx.doi.org/10.1136/bmjopen-2017-019364

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5961613/
https://www.ncbi.nlm.nih.gov/pubmed/29769253
http://dx.doi.org/10.1136/bmjopen-2017-019364

Ejemplares similares